Clinical Study Results
Research Sponsor: AstraZeneca AB
Treatment Studied: Radio-labelled osimertinib
Study Purpose: This study was done to learn how radio-labelled
osimertinib acts in the brains of participants
with non-small cell lung cancer that has
spread to the brain
Protocol Number: D5160C00043
Thank you!
Thank you for taking part in the clinical study for the study drug osimertinib, also
called AZD9291.
AstraZeneca AB sponsored this study and believes it is important to share the
results. An independent non-profit organization called CISCRP helped prepare this
summary of the study results for you.
If you participated in the study and have questions about the results, please speak
with the study doctor or staff at your study site.
1